Skip to main content
Clinical Trials/NCT05968079
NCT05968079CompletedNot Applicable

Performance Comparison Between Masimo W1™ and Apple Watch Series 8

Masimo Corporation2 sites in 1 country20 target enrollmentStarted: September 6, 2023Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
2
Primary Endpoint
Accuracy of Masimo W1™ and Apple Watch Series 8 in Determining SpO2 (Oxygen Saturation) Values in Subjects During Desaturation

Study Overview

Brief Summary

This study is also designed to compare the performance of Masimo W1™ and Apple Watch Series 8 against FDA cleared hospital grade pulse oximetry technology under desaturation conditions.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Subject is 18 to 55 years of age.
  • Subject is American Society Anesthesiologist status 1 (ASA I)
  • Subject has a BMI between 18 and
  • Subject is able to read and communicate in English and understands the study and the risks involved.

Exclusion Criteria

  • Subject is currently taking any medications which in the opinion of the principal investigator would not be suitable for participation in the study.
  • Subject is wearing nail polish that cannot be removed, gel nails, and/or acrylic nails that can interfere with study device's placement.
  • Participants with conditions or skin abnormalities at or around site of sensor placement that could affect the placement on the sensor or prevent monitoring of physiological parameters during the study, such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown.
  • Subject has participated in an investigational drug study within one month prior to the start of the study.
  • Subject has failed the Allen's Test to confirm patency of the collateral artery.
  • Subject is female with a positive pregnancy test, or is female and is unwilling to use effective birth control between the time of screening and study termination.
  • Subject has a positive urine cotinine or drug test.
  • Subject has a reported allergy to Lidocaine.
  • Subject has clinically significant anemia or other hemoglobinopathy.
  • Subject has a room air saturation of less than 95% by pulse oximetry.
  • Subject has a clinically significant abnormal EKG.
  • Subject has a clinically significant abnormal pulmonary function test via spirometry.
  • Subject is intolerant to a breathing mask apparatus.
  • Subject has a COHb greater than 3%, or MetHb greater than 2% verified by laboratory co-oximeter.
  • Subject has another condition, which in the opinion of the principal investigator would not be suitable for participation in the study.
  • Subject is unwilling or unable to provide informed consent or comply with the study procedures.

Outcomes

Primary Outcomes

Accuracy of Masimo W1™ and Apple Watch Series 8 in Determining SpO2 (Oxygen Saturation) Values in Subjects During Desaturation

Time Frame: 1-6 hours

Accuracy will be determined by comparing Masimo W1™ SpO2 measurements and Apple Watch Series 8 SpO2 measurements with FDA-cleared pulse oximetry device SpO2 measurements and calculating the Arithmetic root mean square (ARMS) value. All values presented below for SpO2 (Bias, Precision and ARMS) are in units of %. The pairwise samples consist of paired SpO2 timing measurements from both the reference sensor, Masimo W1, and the Apple Watch.

Successful Read Rate for Motion Conditions Under Slow Desaturation for Masimo W1™ and Apple Watch Series 8

Time Frame: 1-6 hours

This analysis examines the successful read rates for motion conditions during slow desaturation events for the Masimo W1™ and Apple Watch Series 8. The motion condition consists of a combined value representing three types of simulated motion: drinking, scratching the nose, and checking the time. Successful Read Rate = 1 - No Read Rate (Nf / Nspotcheck) x 100 (%) Nf = Number of Reads without Valid SpO2 Nspotcheck = Number of All Spot Checks

Detection Rate of Fast Desaturation Events Under Various Conditions for Masimo W1™ and Apple Watch Series 8

Time Frame: 1-6 hours

Comparison of the detection rate of fast desaturation events under different conditions for the Masimo W1™ and Apple Watch Series 8. The first condition involves no motion, with the palm facing down and the Apple Watch in sleep mode, while the second condition involves no motion, with the palm facing sideways and manual spot checks performed on the Apple Watch. The goal is to evaluate the performance of both devices in detecting desaturation events under these varying circumstances. Detection Rate = (Nt / Ndesat) x 100 (%) Nt = Number of Detected Event by Test Device All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo W1™ and Apple Watch Series 8. Ndesat = Number of All Valid Fast Desaturation Events by Reference SpO2

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Performance Comparison Between Masimo W1™... | Clinical Trial